These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 34534274
1. Bilateral gastrocnemius myositis: an extra-intestinal manifestation of Crohn's disease. Mertz P, Lannes B, Nadaj Pakleza A, Meyer A, Guffroy A. Rheumatology (Oxford); 2022 Feb 02; 61(2):e35-e37. PubMed ID: 34534274 [No Abstract] [Full Text] [Related]
2. Localised gastrocnemius myositis in Crohn's disease. Christopoulos C, Savva S, Pylarinou S, Diakakis A, Papavassiliou E, Economopoulos P. Clin Rheumatol; 2003 May 02; 22(2):143-5. PubMed ID: 12740681 [Abstract] [Full Text] [Related]
3. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial. Colombel JF, Panaccione R, Bossuyt P, Lukas M, Baert F, Vaňásek T, Danalioglu A, Novacek G, Armuzzi A, Hébuterne X, Travis S, Danese S, Reinisch W, Sandborn WJ, Rutgeerts P, Hommes D, Schreiber S, Neimark E, Huang B, Zhou Q, Mendez P, Petersson J, Wallace K, Robinson AM, Thakkar RB, D'Haens G. Lancet; 2017 Dec 23; 390(10114):2779-2789. PubMed ID: 29096949 [Abstract] [Full Text] [Related]
4. Adalimumab for orbital myositis in a patient with Crohn's disease who discontinued infliximab: a case report and review of the literature. Verma S, Kroeker KI, Fedorak RN. BMC Gastroenterol; 2013 Apr 04; 13():59. PubMed ID: 23556424 [Abstract] [Full Text] [Related]
5. Acute gastrocnemius myositis. Another extraintestinal manifestation of Crohn's disease. Drabble EM, Gani JS. Med J Aust; 1992 Sep 07; 157(5):318-20. PubMed ID: 1435473 [Abstract] [Full Text] [Related]
13. Lymphomatoid Papulosis Type B in a Patient with Crohn's Disease Treated with TNF-Alpha Inhibitors Infliximab and Adalimumab. Medvecz M, Kiss N, Hársing J, Kuroli E, Hegede G, Csomor J, Kárpáti S, Marschalkó M. Acta Dermatovenerol Croat; 2019 Sep 23; 27(3):202-204. PubMed ID: 31542070 [Abstract] [Full Text] [Related]
14. Anti-tumor necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease. Núñez-Gómez L, Mesonero-Gismero F, Albillos-Martínez A, López-Sanromán A. Gastroenterol Hepatol; 2018 Nov 23; 41(9):576-582. PubMed ID: 30054143 [Abstract] [Full Text] [Related]
15. [Myositis as the first manifestation of an exacerbation of Crohn's disease]. Oldenburg B. Ned Tijdschr Geneeskd; 2007 Sep 15; 151(37):2071. PubMed ID: 17929719 [No Abstract] [Full Text] [Related]
16. Acute autoimmune sensorineural hearing loss associated with Crohn's disease. Bachmeyer C, Leclerc-Landgraf N, Laurette F, Coutarel P, Cadranel JF, Médioni J, Dhôte R, Mougeot-Martin M. Am J Gastroenterol; 1998 Dec 15; 93(12):2565-7. PubMed ID: 9860428 [Abstract] [Full Text] [Related]
17. [Myositis--a rare complication of Crohn disease]. Druschky A, Heckmann J, Engelhardt A, Neundörfer. Fortschr Neurol Psychiatr; 1996 Oct 15; 64(10):422-4. PubMed ID: 9036102 [Abstract] [Full Text] [Related]